A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)

Clinical trial NCT02004522 · COMPLETED

Trial details

NCT number: NCT02004522
Sponsor: SecuraBio
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma

Start date: 2013-11-01
Primary completion: 2017-05-19
Enrollment: 319

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.